Adderall、兴奋剂与Modafinil治疗ADHD：短期与长期效果

Adderall、兴奋剂与莫达非尼用于ADHD：短期与长期效果

摘要

本集深入探讨Adderall、Vyvanse和Ritalin等兴奋剂药物如何在神经层面发挥作用，通过调节关键脑回路中的Dopamine 多巴胺和去甲肾上腺素来治疗ADHD。Andrew Huberman解释了兴奋剂为何能矛盾地平息过度活跃的症状，探讨了长期发育影响，并介绍了非兴奋剂替代方案，包括莫达非尼和胍法辛。讨论还涵盖了滥用潜力、成瘾风险，以及正确诊断和剂量的关键重要性。

---

核心要点

• 兴奋剂通过提升前额叶皮层协调其他脑网络的能力来治疗ADHD，而非单纯提升整体觉醒水平——目标是改善注意力回路中的信噪比。
• Adderall和Vyvanse并非同一种药物：Adderall是D-苯丙胺和L-苯丙胺以3:1比例混合的制剂；Vyvanse则是纯D-苯丙胺的缓释剂型（严格来说是缓释右旋苯丙胺）。
• Ritalin（哌甲酯）主要增加Dopamine 多巴胺，而Adderall/Vyvanse通过三种不同机制同时增加多巴胺和去甲肾上腺素，而Ritalin仅有一种作用机制。
• 未经治疗的ADHD儿童在成年后滥用非法药物和成瘾的风险显著高于经过治疗的ADHD儿童——药物本身似乎并不会使儿童更易成瘾。
• 剂量因人而异，差异极大且难以预测：一名体重300磅的男性每日仅需2.5 mg的Adderall即有效，而两姐妹则需每日180–240 mg才能产生效果。
• 最佳治疗方案结合药物与行为干预——单独使用药物并不被视为金标准。
• 将ADHD兴奋剂与酒精或苯二氮䓬类药物联用的危害大于单独使用任一物质。
• 现有证据不支持ADHD药物在适当剂量下会抑制身高发育的假说。
• 早期兴奋剂治疗可促进注意力回路的Neuroplasticity 神经可塑性，可能使部分患者随时间推移减少或停止用药。
• 黑市上流通的处方兴奋剂中，约75%含有芬太尼污染，使得非处方获取极为危险。

---

详细笔记

与注意力相关的脑回路

• **prefrontal cortex（前额叶皮层）**位于前额正后方，充当大脑的”指挥家”，协调多个并行网络的活动。
• 它发挥自上而下的抑制作用——主动压制产生分心、冲动和无关内部杂念的回路。
• 与注意力相关的关键网络：
  • Default mode network（默认模式网络，DMN）：在走神、想象和自我参照思维时活跃；在需要专注的任务中通常受到抑制
  • 突显网络：标记重要刺激
  • 背侧注意网络：引导专注、目标导向的注意力
• 在ADHD中，前额叶皮层无法有效协调这些网络——它们往往在不恰当的时机过度连接并同时激活，这也是为什么在需要专注的任务中DMN仍持续活跃。
• ADHD并非单纯的多巴胺或去甲肾上腺素缺乏；它反映的是这些神经调质调节回路活动方式的失调。

兴奋剂在突触水平的作用机制

多巴胺主要减少神经”噪音”——压制来自内部和外部来源的干扰性背景信号。

**Norepinephrine（去甲肾上腺素）**主要放大”信号”——增强参与注意力和学习的回路的显著性和强度。

二者共同提高注意力网络的信噪比。

Adderall和Vyvanse（苯丙胺类）

通过三种机制增加多巴胺和去甲肾上腺素：

1. 阻断突触前多巴胺和去甲肾上腺素转运体（DAT/NET），阻止再摄取
2. 干扰VMAT2（囊泡单胺转运体2），阻止递质重新包装进囊泡——导致突触前末梢内递质积聚
3. 干扰上述蛋白质之间的复杂相互作用，进一步增加释放

• D-苯丙胺：主要作用于大脑；驱动大部分认知和专注效果
• L-苯丙胺：主要产生外周效应（心率加快、血压升高、出汗）
• Adderall：D-苯丙胺与L-苯丙胺的3:1比例混合
• Vyvanse：D-苯丙胺与赖氨酸氨基酸结合→一种前药，在肠道/血液中缓慢裂解，在12–18小时内持续释放D-苯丙胺；降低滥用潜力；~100 mg Vyvanse ≈ ~9 mg Adderall等效剂量

Ritalin / 哌甲酯（Concerta）

通过一种机制增加多巴胺和去甲肾上腺素：

• 阻断多巴胺转运体（DAT），以及较弱程度地阻断去甲肾上腺素转运体
• 对去甲肾上腺素能转运体的亲和力低于苯丙胺类药物
• 主要是多巴胺为主的药物，而非去甲肾上腺素促进剂
• 并非短效Adderall——它是化学结构完全不同的化合物
• 标准起效时间：20–40分钟；持续时间：约4–6小时

兴奋剂为何能平息过度活跃

• 看似矛盾但有充分依据：兴奋剂并非只是镇静过度活跃的儿童
• 通过在适当剂量下增加多巴胺和去甲肾上腺素，它们激活前额叶皮层的协调功能，使其能够适当抑制过度活跃的网络并优先处理相关网络
• 结果是过度连接回路的去同步化——减少冲动性的共同激活
• 目标不是全面抑制，而是网络的适当顺序激活

神经可塑性与长期治疗

• 多巴胺和去甲肾上腺素水平升高可促进**Neuroplasticity 神经可塑性**——强化注意力回路中的突触连接
• 早期治疗的目的不仅是控制症状，还在于训练回路使其更高效运作，即使停药后仍能产生持久效益
• 经过适当治疗的ADHD儿童在长期结果上（学业、行为、物质使用）表现优于未经治疗的同龄人
• PET神经影像学研究显示，早期治疗可促使前脑多巴胺传递在较低阈值下趋于正常化

剂量

• 个体差异极大；目前不存在可靠的预测性检测手段
• 差异主要由药物代谢酶的个体差异决定
• 研究中常见的一般范围（非处方指南）：
  • Adderall：10–40 mg/天
  • Ritalin：10–60 mg/天
  • Vyvanse：通常为数百mg/天（大部分为赖氨酸，而非活性苯丙胺）
• 最佳实践：从最低有效剂量开始，仅在必要时增加
• 临床轶事示例：一名体重300磅的男性每日2.5 mg Adderall即有良好反应；两姐妹则需每日180–240 mg才能产生效果

长期影响与安全性

身高与生长

• 证据不支持在适当剂量下出现显著身高抑制
• 服用药物的ADHD儿童实际上比同龄人的BMI略偏高

心血管风险

• 长期交感神经激活可能升高血压和心率
• 一项大型研究显示心血管风险有轻微上升，但幅度不足以促使作者建议在适当医疗监督下停药
• 缓解策略：避免吸烟/电子烟，坚持规律运动，保持适当剂量

皮质醇与激素

• 慢性交感神经激活可能增加**Cortisol 皮质醇（皮质醇）**水平
• 用药时机对睡眠很重要：短效药物（Ritalin）可能更有利于维持健康的Cortisol 皮质醇节律（夜间保持低水平）
• 关于对内分泌或生殖系统长期影响的数据有限

成瘾潜力

• 经过治疗的ADHD儿童在成年后滥用非法药物和成瘾的比率低于未经治疗的同龄人

---

English Original 英文原文

Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects

Summary

This episode examines how stimulant medications like Adderall, Vyvanse, and Ritalin work at the neurological level to treat ADHD by modulating Dopamine 多巴胺 and norepinephrine in key brain circuits. Andrew Huberman explains why stimulants paradoxically calm hyperactivity, addresses long-term developmental effects, and covers non-stimulant alternatives including modafinil and guanfacine. The discussion also covers abuse potential, addiction risk, and the critical importance of proper diagnosis and dosing.

---

Key Takeaways

• Stimulants treat ADHD by improving the prefrontal cortex’s ability to coordinate other brain networks, not simply by increasing overall arousal — the goal is better signal-to-noise ratio in attention circuits.
• Adderall and Vyvanse are not the same drug: Adderall is a 3:1 mix of D- and L-amphetamine; Vyvanse is time-release D-amphetamine only (technically time-release dexedrine).
• Ritalin (methylphenidate) primarily increases Dopamine 多巴胺, while Adderall/Vyvanse increase both dopamine and norepinephrine through three distinct mechanisms versus Ritalin’s one.
• Untreated ADHD in children carries a significantly higher risk of illicit drug use and addiction in adulthood than treated ADHD — the drugs do not appear to predispose children to addiction.
• Dosage is highly individual and unpredictable: a 300-lb male responded to 2.5 mg of Adderall daily, while two sisters required 180–240 mg daily for effect.
• The optimal treatment approach combines pharmacological and behavioral interventions — drugs alone are not considered the gold standard.
• Combining ADHD stimulants with alcohol or benzodiazepines is more harmful than taking either substance alone.
• Current evidence does not support the hypothesis that ADHD medications stunt height when used at appropriate doses during development.
• Early treatment with stimulants promotes Neuroplasticity 神经可塑性 in attention circuits, potentially allowing some patients to reduce or cease medication over time.
• Up to ~75% of black-market prescription stimulants are contaminated with fentanyl, making non-prescription acquisition extremely dangerous.

---

Detailed Notes

Brain Circuits Involved in Attention

• The prefrontal cortex sits just behind the forehead and acts as the brain’s “orchestra conductor,” coordinating the activity of multiple parallel networks.
• It exerts top-down inhibition — actively suppressing circuits that generate distraction, impulsivity, and irrelevant internal chatter.
• Key networks involved in attention:
  • Default mode network (DMN): active during mind-wandering, imagination, and self-referential thought; normally suppressed during focused tasks
  • Salience network: flags important stimuli
  • Dorsal attention network: directs focused, goal-directed attention
• In ADHD, the prefrontal cortex does not efficiently coordinate these networks — they tend to be hyper-connected and co-active at inappropriate times, which is why the DMN continues firing during tasks that require focus.
• ADHD is not simply a dopamine or norepinephrine deficiency; it reflects a dysregulation of how these neuromodulators tune circuit activity.

How Stimulants Work at the Synapse

Dopamine primarily reduces neural “noise” — suppressing distracting background signals from internal and external sources.

Norepinephrine primarily amplifies “signal” — boosting the salience and strength of circuits involved in attention and learning.

Together, they improve signal-to-noise ratio in attention networks.

Adderall and Vyvanse (amphetamines)

Increase dopamine and norepinephrine through three mechanisms:

1. Block presynaptic dopamine and norepinephrine transporters (DAT/NET), preventing reuptake
2. Disrupt VMAT2 (vesicular monoamine transporter 2), preventing repackaging of transmitters into vesicles — leading to buildup in the presynaptic terminal
3. Disrupt the complex interaction between the above proteins, further increasing release

• D-amphetamine: primarily acts in the brain; drives most of the cognitive and focus effects
• L-amphetamine: primarily peripheral effects (increased heart rate, blood pressure, sweating)
• Adderall: 3:1 ratio of D- to L-amphetamine
• Vyvanse: D-amphetamine bonded to lysine amino acid → a prodrug that is slowly cleaved in the gut/bloodstream, producing timed-release D-amphetamine over 12–18 hours; reduces abuse potential; ~100 mg Vyvanse ≈ ~9 mg Adderall equivalent

Ritalin / Methylphenidate (Concerta)

Increases dopamine and norepinephrine through one mechanism:

• Blocks the dopamine transporter (DAT) and to a lesser extent the norepinephrine transporter
• Lower affinity for the noradrenergic transporter than amphetamines
• Primarily a dopamine-dominant drug, not a norepinephrine booster
• Not short-acting Adderall — it is a chemically distinct compound
• Standard onset: 20–40 minutes; duration: ~4–6 hours

Why Stimulants Calm Hyperactivity

• Counterintuitive but well-supported: stimulants don’t just sedate hyperactive children
• By increasing dopamine and norepinephrine at appropriate doses, they activate the prefrontal cortex’s coordinating function, allowing it to properly suppress over-active networks and prioritize relevant ones
• The result is desynchronization of hyperconnected circuits — reducing impulsive co-activation
• The goal is not global suppression, but proper sequential activation of networks

Neuroplasticity and Long-Term Treatment

• Elevated dopamine and norepinephrine promote Neuroplasticity 神经可塑性 — strengthening synaptic connections in attention circuits
• Early treatment is designed not only to manage symptoms but to train circuits to function more efficiently, with lasting benefits even after medication cessation
• Children with ADHD treated appropriately show better long-term outcomes (academic, behavioral, substance use) than untreated peers
• PET neuroimaging studies show early treatment leads to normalization of dopamine transmission in the forebrain at lower thresholds later in life

Dosage

• Highly variable across individuals; no reliable predictive test exists
• Variation is largely driven by differences in drug-metabolizing enzymes
• General ranges seen in research (not prescriptive guidelines):
  • Adderall: 10–40 mg/day
  • Ritalin: 10–60 mg/day
  • Vyvanse: typically 100s of mg/day (most is lysine, not active amphetamine)
• Best practice: start at the lowest effective dose, increase only as needed
• Anecdotal clinical example: a 300-lb male responded well to 2.5 mg Adderall/day; two sisters required 180–240 mg/day for effect

Long-Term Effects and Safety

Height and Growth

• Evidence does not support significant height stunting at appropriate doses
• Children with ADHD on medication actually trend toward slightly higher BMI than age-matched peers

Cardiovascular Risk

• Long-term sympathetic activation can elevate blood pressure and heart rate
• One major study showed a subtle increase in cardiovascular risk, but not enough for authors to recommend discontinuation under proper medical supervision
• Mitigation strategies: avoid smoking/vaping, engage in regular exercise, maintain appropriate dosing

Cortisol and Hormones

• Chronic sympathetic activation likely increases Cortisol 皮质醇 levels
• Timing of dosing matters for sleep: shorter-acting medications (Ritalin) may be preferable for preserving healthy Cortisol 皮质醇 rhythms (low at night)
• Limited long-term data on effects on the endocrine or reproductive systems

Addiction Potential

• Treated ADHD children have lower rates of illicit drug use and addiction in adulthood vs